AMPHIREGULIN AND EPIREGULIN POLYMORPHISMS AS PHARMACOGENETIC PREDICTIVE FACTORS FOR RESPONSE TO IRINOTECAN PLUS ANTI-EGFR TREATMENT

被引：0
|
作者：
Sebio Garcia, A. [1 ]
Paez, D. [1 ]
Salazar Blanco, J. [1 ]
Tobena Puyal, M. [1 ]
Martin-Richard, M. [1 ]
Barnadas, A. [1 ]
Baiget, M. [1 ]
机构：
[1] Santa Creu & St Pau Hosp, Deparment Genet, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [21] Predictive factors in the response of antiplatelet anti EGFR in Gastro intestinal tumor
    Puig, Pierre-Laurent
    Lievre, Astrid
    THERAPIE, 2007, 62 (02): : 95 - 98
  • [22] Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: Implications for anti-EGFR treatment response
    Boeckx C.
    Weyn C.
    Vanden Bempt I.
    Deschoolmeester V.
    Wouters A.
    Specenier P.
    Van Laer C.
    Van Den Weyngaert D.
    Kockx M.
    Vermorken J.B.
    Peeters M.
    Pauwels P.
    Lardon F.
    Baay M.
    BMC Research Notes, 7 (1)
  • [23] 89Zr-labeled domain II specific anti-EGFR ScFv-Fc antibody fragment for imaging and monitoring of response to anti-EGFR treatment by PET
    Alizadeh, Elahe
    Solomon, Viswas Raja
    Zuluaga, Carolina
    Bernhard, Wendy
    Makhlouf, Amal
    Barreto, Kris
    Geyer, Clarence
    Fonge, Humphrey
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [24] The value of p16 or HPV as predictive marker of anti-EGFR treatment in recurrent/metastatic HNSCC
    Lim, Joo Han
    Hong, Soon-Sun
    Kim, Jin-Chul
    Lee, Moon Hee
    Cho, Jinhyun
    CANCER RESEARCH, 2018, 78 (13)
  • [25] Radiotherapy plus the anti-EGFR mAb nimotuzumab or placebo for the treatment of high-grade glioma patients
    Teresa Solomon, Maria
    Cesar Selva, Julio
    Figueredo, Javier
    Vaquer, Jose
    Toledo, Carolina
    Quintanal, Nelson
    Salva, Silvia
    Dominguez, Rafael
    Alert, Jose
    Juan Marinello, Jorge
    Catala, Mauricio
    Gonzalez Griego, Martha
    Lorenzo Luaces, Patrcia
    Iznaga, Normando
    Bach, Ferdinand
    Crombet Ramos, Tania
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer
    N Takahashi
    Y Yamada
    K Furuta
    Y Honma
    S Iwasa
    A Takashima
    K Kato
    T Hamaguchi
    Y Shimada
    British Journal of Cancer, 2014, 110 : 2716 - 2727
  • [27] BUDGETARY IMPACT OF FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER BASED ON XELOX plus ANTI-VEGF OR XELOX plus ANTI-EGFR
    Gomez, E.
    Torrecillas, L.
    Cervantes, L.
    VALUE IN HEALTH, 2011, 14 (07) : A543 - A543
  • [28] High Amphiregulin and Epiregulin expression in K-ras wild type colorectal primaries predicts response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease
    Tejpar, Sabine
    De Roock, Wendy
    Biesemans, Bart
    De Schutter, Jef
    Piessevaux, Hubert
    Humblet, Yves
    Peeters, Marc
    Celik, Ilhan
    Van Cutsem, Eric
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3466S - 3466S
  • [29] EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis
    Zu-Yao Yang
    Wei-Xi Shen
    Xue-Feng Hu
    Da-Yong Zheng
    Xin-Yin Wu
    Ya-Fang Huang
    Jin-Zhang Chen
    Chen Mao
    Jin-Ling Tang
    Journal of Hematology & Oncology, 5
  • [30] EGFR gene copy number as a predictive biomarker for the treatment of metastatic colorectal cancer with anti-EGFR monoclonal antibodies: a meta-analysis
    Yang, Zu-Yao
    Shen, Wei-Xi
    Hu, Xue-Feng
    Zheng, Da-Yong
    Wu, Xin-Yin
    Huang, Ya-Fang
    Chen, Jin-Zhang
    Mao, Chen
    Tang, Jin-Ling
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
12345